WHO. Konzo: A distinct type of upper motoneuron disease. Wkly Epidemiol Rec1996; 71: 225–232.
2.
TrolliG. Paraplégie spastique épidémique: “Konzo” des indigènes du Kwango. In: TrolliG (ed). Résumé des Observations Réunies, au Kwango, au Sujet de Deux Affections d'Órigine Indéterminée. Brussels: Fonds Reine Elisabeth; 1938. 1–36.
3.
TylleskärTBaneaMRoslingH. Konzo: An upper motoneuron disease associated to cassava and agro-ecological collapse in Africa. In: RoseClifford F, (ed). Recent Advances in Tropical Neurology. Amsterdam: Elsevier; 1995: 355–366.
4.
RoslingHTylleskärT. Neurotoxicological effects of cassava cyanogenesis. In: SpencerPSSchaumburgH, (eds). Experimental and Clinical Neurotoxicology. Oxford: Oxford University Press; 2000.
5.
TylleskärTHowlettWRwizaH. Konzo: A distinct disease entity with selective upper motoneuron damage. J Neurol Neurosurg Psychiatry1993; 56: 638–643.
6.
BaneaMTylleskärTRoslingH. Konzo and Ebola in Zaire. Lancet1997; 349: 621.
7.
Eeg-OlofssonO. The development of the electroencephalogram in normal children and adolescents from the age of 1 through 21 years. Acta Paediatr Scand1970; (suppl) 208: 1–46.
8.
Eeg-OlofssonOPetersénISelldénU. The development of the electroencephalogram in normal children from the age of 1 through 15 years: Paroxysmal activity. Neuropediatrics1971; 2: 375–404.
9.
GetahunHMekonnenAHaimanotRTLambeinF. Epidemic of neurolathyrism in Ethiopia. Lancet1999; 354: 306–307.
10.
KiraJMinatoSItoyamaYGotoIKatoMHasuoK. Leukoencephalopathy in HTLV-I-associated myelopathy: MRI and EEG data. J Neurol Sci1988; 87: 221–232.
11.
YonenagaYArimuraKSueharaMArimuraYOsameM. Electroencephalographic abnormalities in human T-cell lymphotropic virus type I-associated myelopathy. Arch Neurol1989; 46(5): 513–516.